Abstract
This clinical case presents a 55-year-old man with a locally-advanced malignant kidney tumor. The patient receives a radical nephrectomy and adjuvant pembrolizumab. The patient develops hypereosinophilia with organ-specific kidney injury. By means of applying the Naranjo test, we concluded that this adverse event was caused by immunotherapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
